Cite
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
MLA
Ackermann, Dm, et al. Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow-up? A Protocol for the MEL-SELF Randomised Controlled Trial. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315666403&authtype=sso&custid=ns315887.
APA
Ackermann, D., Smit, A., Janda, M., van Kemenade, C., Dieng, M., Morton, R., Turner, R., Cust, A., Irwig, L., Hersch, J., Guitera, P., Soyer, H., Mar, V., Saw, R., Low, D., Low, C., Drabarek, D., Espinoza, D., Emery, J., … Bell, K. (2021). Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.
Chicago
Ackermann, Dm, Ak Smit, M Janda, Ch van Kemenade, M Dieng, Rl Morton, Rm Turner, et al. 2021. “Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow-up? A Protocol for the MEL-SELF Randomised Controlled Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315666403&authtype=sso&custid=ns315887.